Theianova
1 known investors
TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Theianova do?
- TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.
- Who are Theianova's investors?
- Theianova's investors include Bridgewest Ventures.